Skip to main content

Advertisement

Log in

Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. WHO (2019) Global tuberculosis report, 2019. http://who.int/tb/publications/global_report/en. Accessed 29 Jan 2020

  2. Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson M-C, Salfinger M, Somoskövi A, Warshauer DM, Wilson ML (2018) Practice guidelines for clinical microbiology laboratories: mycobacteria. Clin Microbiol Rev 31(2):e00038–e00017

    Article  CAS  Google Scholar 

  3. Centers for Disease Control and Prevention (CDC) (2009) Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 58:7–10

    Google Scholar 

  4. Boehme C, Nabeta P, Hillemann D, Nicol M, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O’Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD (2010) Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med 363:1005–1015

    Article  CAS  Google Scholar 

  5. Theron G, Peter J, Calligaro G, Meldau R, Hanrahan C, Khalfey H, Matinyenya B, Muchinga T, Smith L, Pandie S, Lenders L, Patel V, Mayosi BM, Dheda K (2014) Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments. Sci Rep 4:5658

    Article  CAS  Google Scholar 

  6. Detjen AK, DiNardo AR, Leyden J, Steingart KR, Menzies D, Schiller I, Dendukuri N, Mandalakas AM (2015) Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med 3:451–461

    Article  Google Scholar 

  7. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 8(7):e1001067

    Article  Google Scholar 

  8. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D (2017) The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio 8:e00812–e00817

    Article  Google Scholar 

  9. Clinical and Laboratory Standards Institute (2011) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. 2nd ed. Wayne: CLSI; Approved standard. CLSI document M24-A2

  10. Cepheid (2017) Xpert MTB/RIF ULTRA assay (package insert). Sunnyvale

  11. Rindi L, Garzelli C (2016) Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis 16:44

    Article  Google Scholar 

  12. Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Peres RL, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM, study team (2018) Xpert MTB/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis 18:76–84

    Article  CAS  Google Scholar 

  13. Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G, Jaton K (2019) Added value of Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in a low-prevalence setting. J Clin Microbiol 57(2):e01717–e01718

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Osei Sekyere J, Maphalala N, Malinga LA, Mbelle NM, Maningi NE (2019) A comparative evaluation of the new Genexpert MTB/RIF Ultra and other rapid diagnostic assays for detecting tuberculosis in pulmonary and extra pulmonary specimens. Sci Rep 9:16587

    Article  Google Scholar 

  15. Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, Alcaide F (2018) Evaluation of the Xpert MTB/RIF Ultra assay for direct detection of Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples. J Clin Microbiol 56(9):e00659–e00618

    Article  CAS  Google Scholar 

  16. Wu X, Tan G, Gao R, Yao L, Bi D, Guo Y, Yu F, Fan L (2019) Assessment of the Xpert MTB/RIF Ultra assay on rapid diagnosis of extrapulmonary tuberculosis. Int J Infect Dis 81:91–96

    Article  Google Scholar 

  17. Hodille E, Maisson A, Charlet L, Bauduin C, Genestet C, Fredenucci I, Rasigade JP, Lina G, Dumitrescu O (2019) Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre. Eur J Clin Microbiol Infect Dis 38:601–605

    Article  Google Scholar 

  18. Piersimoni C, Gherardi G, Gracciotti N, Pocognoli A (2019) Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence setting. J Clin Tuberc Other Mycobact Dis 15:100094

    Article  Google Scholar 

  19. Theron G, Venter R, Smith L, Esmail A, Randall P, Sood V, Oelfese S, Calligaro G, Warren R, Dheda KJ (2018) False-positive Xpert MTB/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes. Clin Microbiol 56(3)

  20. Kendall EA, Schumacher SG, Denkinger CM, Dowdy DW (2017) Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: a modeling study. PLoS Med 14(12):e1002472

    Article  Google Scholar 

  21. Ocheretina O, Byrt E, Mabou MM, Royal-Mardi G, Merveille YM, Rouzier V, Fitzgerald DW, Pape JW (2016) False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis 85:53–55

    Article  Google Scholar 

  22. Williamson DA, Basu I, Bower J, Freeman JT, Henderson G, Roberts SA (2012) An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 74:207–209

    Article  CAS  Google Scholar 

Download references

Funding

This work was financially supported by the University of Pisa, grant “Fondi di Ateneo, 2018.”

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Rindi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was in accordance with the ethics committee of the University of Pisa.

Informed consent

Our study was based on the retrospective analysis of anonymous patient data only.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Menichini, M., Lari, N., Lupetti, A. et al. Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center. Eur J Clin Microbiol Infect Dis 39, 1597–1600 (2020). https://doi.org/10.1007/s10096-020-03867-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-020-03867-y

Navigation